申请人:Sankyo Company,. Limited
公开号:US05712267A1
公开(公告)日:1998-01-27
Compounds of formula (I): ##STR1## wherein R.sup.1x is hydrogen or methyl, R.sup.2x is hydrogen optionally substituted aliphatic hydrocarbon or acylimidoyl, R.sup.3x is hydrogen or an ester group, and Q.sup.x is cyclic or acyclic nitrogen-containing group. The compounds are potent antibiotics which are resistant to dehydropeptidase I, and are thus useful for the treatment of many microbial infections.
式(I)的化合物:##STR1## 其中R.sup.1x为氢或甲基,R.sup.2x为氢或可选择的取代脂肪烃基或酰基亚咪唑基,R.sup.3x为氢或酯基,Q.sup.x为环状或非环状含氮基团。这些化合物是强效的抗生素,对去氢肽酶I具有抗性,因此可用于治疗许多微生物感染。